East Carolina University. Tomorrow starts here.®
 




 


Dr

 

Jan Wong, MD
Professor of Surgical Oncology
Director, Breast Care Center

 

Address:
Brody School of Medicine
East Carolina University
600 Moye Boulevard
Greenville, NC 27834
Phone: (252) 744-4110
E-mail: wongj@ecu.edu

Current Professional and Academic Appointment:
2010 - present Professor, Department of Surgery, Brody School of
Medicine, East Carolina University, Greenville, North Carolina

Licensure:
North Carolina, Oregon, California, Hawaii

Certification:
Diplomate, National Board of Medical Examiners 1979
Diplomate, American Board of Surgery 1986
Diplomate, American Board of Surgery 1994
Diplomate, American Board of Surgery 2003

Education:
1971-74 BA  Stanford University, Standford, California
1974-78 MD Rush Medical College, Chicago, Illinois

Postgraduate Training:
1978-79 Intern, The University of Oregon Health Sciences
Center, Portland, Oregon

1979-84 Resident, Oregon Health Sciences University
Portland, Oregon

1981-83 Clinical Fellow, American Cancer Society
Oregon Health Sciences University, Portland, Oregon

1984-85 Chief Resident in Surgery, Oregon Health Sciences
University, Portland, Oregon

1985-87 Fellow in Surgical Oncology, Tumor Immunology Training Grant
in Surgical Oncology, University of California at Los Angeles School
Of Medicine, Los Angeles, California

1986-87 Clinical Fellow, American Cancer Society
University of California at Los Angeles School of Medicine
Los Angeles, California

Professional Society Memberships:

1985  Member Association for Academic Surgery          
1988  Member American Society of Clinical Oncology   
1988  Member American Association for Cancer Research   
1989  Fellow, American College of Surgeons              
1989-1993  Member Southern California Chapter, American College
of Surgeons
1990  Member Society of Surgical Oncology              
1992  Member Pacific Coast Surgical Association              
1992  Member American Association for the Advancement of Science.       
1993  Member American Radium Society              
1995  Member Hawaii Chapter, American College of Surgeons  
1995  Member Society for Surgery of the Alimentary Tract        
1999  Member Western Surgical Association

Academic Appointments:

1985-1991 Adjunct Assistant Professor of Surgery 
UCLA School of Medicine, Los Angeles, California

1987-1993 Staff Surgeon, Sepulveda Veterans
Medical Center, Sepulveda, California 

1988- 1993 Chief, Section Surgical Oncology 
Sepulveda Veterans Medical Center, Sepulveda, California

1991-1993  Associate Professor of Surgery  
UCLA School of Medicine Los Angeles California

1993-2005    Professor of Surgery     
John A. Burns School of Medicine 
University of Hawaii at Manoa Honolulu, Hawaii

1998-2005  Director, Program in Sentinal Node Surgery
and Biology University of Hawaii School of Medicine  

2000-2006  Prevention and Control Program      
Cancer Research Center of Hawaii  
University of Hawaii at Manoa Honolulu, Hawaii

2006-2009  Professor of Surgery Chief of Surgical Oncology 
Loma Linda University School of Medicine Loma Linda, California           

Hospital Appointments:

1985-1993 Attending Surgeon,   UCLA Center for Health Sciences,
Los Angeles, California

1987-1993 Staff Surgeon, Sepulveda Veterans Administration
Medical Center,  Sepulveda, California.  
      
1994-2006 Attending Surgeon, The Queen's Medical Center, Honolulu, Hawaii
  
1996-2006 Consulting Surgeon, St. Francis Medical Center, Honolulu, Hawaii

2006-2010 Attending Surgeon, Loma Linda University Medical Center

Committees:

Hospital:  
1988-1993 Medical Record Review Committee,
Sepulveda VA Medical Center, Sepulveda, CA

1989-1993 Chief, Cancer Committee, Sepulveda VA Medical Center,
Sepulveda, CA 

1991-1993 Surgery Center Policy Committee, UCLA School
of Medicine, Los Angeles, CA

1992-1993  Member UCLA Comprehensive Breast Center,
UCLA Medical Center, Los Angeles, CA

1993 Member UCLA Operations Excellence Task Force
on Process Simplification, UCLA Medical Center, Los Angeles, CA        

1994-1997 Member Continuing Medical Education Committee,
Straub Health Foundation, Honolulu, HI

1994-1998 Member, Institute of Cancer Committee,
St. Francis Medical Center, Honolulu, HI

1995-2001 American College of Surgeon, Cancer Liaison
Physician of the Commission on Cancer, St. Francis Medical
Center, Honolulu, HI

1998-2000 Member, Department of Oncology Peer Review,
Queen's Medical Center, Honolulu, HI

2001-2006 Member Scientific Review Committee, Queen's Medical
Center, Honolulu, HI.

2003-2004    Peer Review Committee, Queen’s Medical Center, Honolulu, HI.

2005-2006 Chairman, Peer Review Committee, St. Francis
Medical Center, Honolulu,    HI.          

2006 Cancer Committee, St. Francis Medical Center, Honolulu, HI.

2006  General & Pediatric Surgery QI, Loma Linda University Medical Center,
Loma Linda CA 

2006-Cancer Committee, Loma Linda University Medical Center, Loma Linda, CA.

University:

1987-1993  Member Jonnson Comprehensive Cancer Center, UCLA
School of  Medicine, Los Angeles, CA. 

1988-1991 Quality Assurance Committee, Division Surgical Oncology, UCLA   
School of Medicine, Los Angeles, CA.

1991-1993 Human Subjects Protection Committee, UCLA School of
Medicine, Los Angeles, CA.

1991-1993 Quality Assurance Coordinator, Division Surgical Oncology,
UCLA School of Medicine, Los Angeles, CA.

1991-1993  Quality of Care Assessment Committee, UCLA Medical Center, Los 
Angeles
, CA
.

1992-1993 Internal Grant Peer Review Committee, Jonsson
Comprehensive Cancer Center, UCLA School of Medicine, Los Angeles, CA       

1994-1997     Committee on Human Studies, University of Hawaii, Honolulu, HI.

2001-2004  Appointment, Promotion and Tenure Committee, University of
Hawaii School of Medicine, Honolulu, HI.

2005-2006   Committee on Human Studies, Universityof Hawaii, Honolulu, HI.

2006-2009 Clinical Faculty Executive Committee, Loma Linda University           

2006-2009 Promotions Commiteee, Department of General and
Trauma Surgery, Loma Linda University

2006-2009 Quality Improvement Committee, Department of General and
Trauma Surgery, Loma Linda University 2009 Pain Management Committee, Loma Linda University Medical Center

National:

1992 Education Committee, Society of Surgical Oncology.       

1998 External Scientific Review Committee, A Phase III
prospective,  randomized, adjuvant trial of chemotherapy and either
tamoxifen or toremifene in premenopausal women with estrogen receptor 
positive  invasive breast cancer who have been staged with lymphatic              
mapping and sentinel node biopsy.   

2004-2006  Program Committee Pacific Coast Surgical Association

Publications:

Bibliography 

1.  Wickre CG, Baur GM, Wong JH, Woodruff J, Bagby SP:  Extracellular volume
expansion and delay resolution of hypertension after canine aortic coarctectomy. 
Life Sci 1982;32:1197-1206.  

2.  Jackson CF, Palmquist M, Swanson J, Wong JH, Miller SH, Demuth RJ,
Fletcher WS: The effectiveness of prophylactic subcutaneous mastectomy in
Sprague-Dawley rats induced with 7-12 dimethylbenzanthracene. Plastic Reconst Surg 1984;73:249-260. 

3.  Wong JH, Krippaehne WW, Fletcher WS:  Percutaneous transhepatic biliary decompression:  Results and complications in 30 patients. Amer J Surg
1984;146:615-618.  

4.  Wong JH, Jackson CF, Swanson JS, Miller SH, Demuth RJ, Fletcher WS:
Analysis of the risk reduction of prophylactic partial mastectomy in
Sprague-Dawley rats with 7-12 dimethylbenzanthracene-induced breast cancer.
Surgery 1986;90:67-71.  

5.  Hartley JW, Awrich AE, Wong JH, Stevens K, Fletcher WS:  Diagnosis and
treatment of the inferior vena cava syndrome in advanced malignant disease.
Am J Surg 1986; 152:70-74.  

6.  Wong JH, Gupta RK, Morton DL:  Serial determinations of melanoma tumor
associated antigen and antibody in stage I melanoma patients. Arch Surg 1986;
121:1342-1346.  

7.  Wong JH, Cagle LA, Storm FK, Morton DL:  The natural history of surgically
treated primary mucosal melanoma. Am J Surg 1987;154:54-58.  

8.  Wong JH, Cagle LA, Morton DL:  Surgical treatment of melanoma metastatic
to lymph nodes from an unknown primary. Arch Surg 1987;122:1380-1384.  

9.  Hartley JW, Wong JH, Fletcher WS:  Response of advanced breast cancer to
total endocrine ablation after exacerbation on tamoxifen. Results in
seven patients and possible mechanism of action. J Surg Onc 1987;34:182-187.  

10.  Wong JH, Gupta RK, Morton DL:  Demonstration of a well characterized
tumor associated antigen on melanoma cell surface. J Surg Onc 1988;38:147-150. 

11.  Wong JH, Euhus DM, Morton, DL:  Surgical Resection of melanoma
metastatic to lung.  Arch Surg 1988;123:1091-1095.  

12.  Wong JH, Gupta RK, Morton DL:  Recovery of a cell surface fetal antigen
from immune complexes of melanoma patients.  Cancer Immunol Immunother
1988; 27:142-146.  

13.  Essner RS, Wong JH, Economou JE, Morton DL:  Prognostic significance of
melanoma arising in the scalp.  Am J Surg 1988;156:314-317.  

14.  Wong JH, Sterns E, Kopald KH, Nizze JA, Morton DL:  Prognostic significance
of pregnancy in Stage I melanoma.  Arch Surg 1989;124:1227-1231.

15.  Sondak VK, Wong JH, Lazar GS, Kern DH, Storm FK:  Cytosine arabinoside
and cisplatin isolation perfusion for the treatment of malignant melanoma:
clinical validation of an invitro observation. Reg Cancer Treat 1989;2:125-130.

16.  Wong JH, Irie RK, Morton DL:  Human monoclonal antibodies: Prospects for
therapy of human cancer.  Sem Surg Oncology 1989;5:448-452.

17.  Wong JH, Xu SH, Gupta RK, Morton DL:  Tumor associated antigen specific
circulating immune complexes: A marker of recurrent melanoma.
Arch Surg 1990;125:187-191.

18.  Goffney WH, Wong JH, Kern DH, Chase D, Krag DN, Storm FK: 
Rhodamine 123 combined with hyperthermia is cytotoxic for human
malignant cells in vitro and retards the growth of a human melanoma
implanted in nude mice. Cancer Res 1990;49:459-465.

19.  Wong JH, Xu SH, Saxton RE, Gupta RK, Morton DL:  Detection and isolation
of antigen specific immune complexes from sera of melanoma patients. 
Int J Cancer 1990;45:445-449.

20.  Wong JH, Xu SH, Saxton RE, Gupta RK, Morton DL:  Immunochemical
characterization of a tumor associated antigen defined by a monoclonal
antibody. J Surg Res 1990;48:539-546.

21.  Wong JH, Cagle LA, Kopald KH, Swisher SG, Morton DL:  Selective
management of intransit metastatic melanoma.
J Surg Oncology 1990;44:146-150.

22.  Wong JH, Kopald KH, Morton DL:  The impact of microinvasion on
axillary node metastases and survival in patients with intraductal breast cancer.
Arch Surg 1990; 125:1298-1302.

23.  Wong JH, Wanek L, Chang LC, Goradia T, Morton DL:  The importance of
anatomic site on prognosis of patients with cutaneous melanoma. Arch Surg
1991;126:486-489.

24.  Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH:  Improved long-term
survival following lymphadenectomy of melanoma metastatic to regional nodes: 
Analysis of prognostic factors in 1,134 patients from the John Wayne Cancer Clinic. 
Ann Surg 1991;214:491-501.

25.  Wong JH, Cagle LA, Morton DL:  Lymphatic drainage of skin to a sentinel
lymph node in a feline model.  Ann Surg 1991;214:637-641.

26.  Wong JH, Xu SH, Foshag LJ, Skinner KF, Morton DL:  Prospective evaluation
of the utility of antigen specific immune complexes in predicting recurrent
melanoma. Arch Surg 1991;126:1450-1454.

27.  Layfield LJ, Parkinson B, Wong JH, Giuliano AE, Bassett LW: 
Mammographically guided fine needle aspiration biopsy of non-palpable breast
lesions: Can it replace open biopsy? Cancer 1991;68:2007-2011.

28.  Morton DL, Wen DR, Wong JH, Cagle LA, Economou JS, Foshag LJ, Cochran AJ: Intraoperative lymphatic mapping and selective lymphadenectomy:
Technical details of a new procedure for clinical stage I melanoma.
Arch Surg 1992;127:392-399.

29.  Euhus DM, Wong JH:  Appraisal of anti-idiotypic antibodies in the treatment
of human solid tumors.  Surg Gynecol Obstet 1992;175:89-95.

30.  Wong JH, Skinner KA, Kim KA, Foshag LJ, Morton DL:  The role of surgery in
treatment of non-regional metastastic melanoma.  Surg 1993;113:389-394.

31.  Law MM, Wong JH:  Evaluation of the prognostic significance of site of origin
in cutaneous melanoma.  Am Surg 1994;60:362-366.

32.  Wong JH:  The implications of Hawaii's sun for it's multi-ethnic immigrant
population:  Cutaneous melanoma in the 21st century.  Proceedings of the
Straub Foundation 1994;58:49-52.

33.  Williams SB, Law MM, Wong JH:  The role of surgery in the management of
lymphoma of the gastrointestinal tract. J Surg Oncol 1996;61:199-204.

34.  Reintgen D, Slingluff C, Wong JH, Seigler HF. Pregnancy in association with
malignant melanoma.  Clinical Consultations in Obstetrics and Gynecology 1996.

35.  Wong JH, Truelove K, Ko P, Coel MN. Localization and resection of an
intransit sentinel lymph node utilizing lymphoscintigraphy, intraoperative
lymphatic mapping, and a hand held gamma probe.
Surgery 1996;120:114-116.

36.  Wong JH, Terada K, Ko P, Coel MN.  Lack of effect of particle size on the
identification of the sentinel node in cutaneous malignancies. Ann Surg Oncol
1998;5:77-80.

37.  Rodrigues LKE and Wong JH. New approaches to the management of malignant melanoma. Proc Straub Found 1998;62:62-64.

38.  Terada KY, Coel MN, Ko P, Wong JH. Intraoperative Lymphatic Mapping in
Squamous Cell Cancer of the Vulva. Gynecol Oncol 1998;70:65-69.

39.  Bowles J, Terada KY, Coel MN, Wong JH. Preoperative lymphoscinitgraphy in the evaluation of squamous cell cancer of the vulva. J Clin Nuc Med 1999;24:235-238.

40. Wong JH, Severino R, Honnebier MB, Tom P, Namiki T. Number of nodes
examined and staging accuracy in colorectal carcinoma.
J Clin Oncol 1999;17:2896-2900.

41.  Terada KY, Shimuzu DM, Wong JH.  Micrometastases and sentinel node
dissection in squamous cell cancer of the vulva. Gynecol
Oncol 2000;76:40-44. 48.

42.  Wong JH, Steinemann S, Yonehara, C, Coel MN, Ko PJ. Sentinel lymph node
staging in a university affiliated community care setting. 
Ann Surg Oncol 2000;7:450-455.

43.  Leong SPL, Morita ET, Tressler PA, Wong JH.  Multidisciplinary approach to
selective sentinel lymph node mapping in breast cancer. Breast Cancer 2000;
7:105-113.

44.  Wong JH:  Historical Perspective of Sentinel Lymph Node. Surg
Clinics of North America  2000;80:16751682.

45.  Wong JH:  The role of sentinel lymph nodes in gynecological malignancies
and other solid cancers.  Surg Clinics of North America  2000;80:1787-1798.

46.  Wong JH:  Selective Sentinel Lymphadenectomy:  University Research Tool
or Community Practice Technique? Surg Clinics of North
America 2000;80:1821-1830.

47.  Leong  SPL and Wong JH:  Future Perspective of Sentinel Lymph node
in the Management of Cancer. Surg Clinics of North America. 
2000;80:1839-1844.

48.  Saha S, Nora D, Wong JH:  Sentinel Node Surgery in Carcinoma of
the Colon. Surg Clinics of North America 2000;80:1811-1820.

49.  Wong JH, Steineman S, Calderia C, Bowles J, Namiki T.  Ex vivo sentinel
node mapping in carcinoma of the colon and rectum. Ann Surg
2001;233:515-521.

50.  Wong JH, Steineman S, Ko PJ, Wong DL.  The value of breast
lymphoscintigraphy in breast sentinel node staging.  Clin Nuc Med 2001;26:502-505.

51.  Rodrigues L, Leong, SPL, Kashani-Sabet, M, Wong JH.  Early experience
with sentinel lymph node mapping for Merkel cell carcinoma. J Am
Acad Derm 2001;45:303-308.

52.  Wong JH, Severino R, Honnebier, Tom P, Namiki TS.  Number of nodes
examined and staging accuracy in colorectal carcinoma-Author Update.
Classic Papers Current Comments: Gastrointestinal Oncology, J Clin Oncol 2002;6:844-848.

53.  Wong JH, Steinemann S, Tom P, Tauchi-Nishi, P.  Prognostic Significance of
the volume of lymphatic metastases in colorectal cancer. J Clin
Oncol 2002;20:1506-1511.

54.  Sera MJ, Yonehara C, Ko PJ, Wong JH.  The impact of time on the number of
sentinel nodes imaged by cutaneous lymphoscintigraphy in patients with melanoma. 
Clin Nuc Med 2002;27:648-652.

55.  Wong JH, Bowles, JB, Bueno R, Shimizu D.  The impact of the number of
negative nodes on disease-free survival in colorectal cancer patients.  Dis Colon
Rectum 2002; 45:1341-1348.

56.  Wong JH.  Improved methods to stage cancer:  The evolving role of sentinel
node staging in solid malignancies.  Hawaii Med J 2002;61:260-262.

57.  Wong JH.  Rationale and development of sentinel node dissection. Cancer
Treat Res 2002;111:1-7.

58.  Johnson DS, Yamane S, Yonehara C, Morita S, Wong JH. 
Malignant melanoma in Non-Caucasians:  Experience from Hawaii. 
Surg Clin N Amer 2003;83:275-282.

59.  Johnson DS, Wong JH.  The impact on nodal staging of lymphatic mapping
in colorectal cancer.  Sem  Oncol 2004;31:403-408.

60.  Wong JH, Johnson DS, Tauchi-Nishi P, Namiki T.  Ex Vivo Sentinel Node
Mapping in Carcinoma of the Colon and Rectum:  Validation of the Hypothesis. 
Ann Surg Oncol 2004;11:772-777.

61.  Tominaga GT, Garcia G, Dzierba A, Wong JH.  Amphetamines-Its toll on the
trauma system. 
Arch Surg 2004;139:844-847.

62.  Hemmings D, Johnson DS, Tominaga GT, Wong JH.  Cutaneous melanoma in
a multi-ethnic population:  Is this a different disease?  Arch Surg 2004; 139:968-973.

63.  Steinemann S, Roytman T, Chang J, Holzman J, Hishinuma E, Nagoshi M,
Tam E, Wong JH.  Impact of education on smoking cessation counseling by
surgical residents. Am J Surg 2005;189:44-46.

64.  Wong JH, Johnson DS, Hemmings D, Hsu A, Imai T, Tominaga GT.  Assessing
the quality of colorectal cancer staging:  Documenting the process in improving the
staging of node negative colorectal cancer patients.  Arch Surg 2005;140:881-886.

65.  Wong JH.  The development of lymphatic mapping and selective lymphadenectomy: a historical perspective.  Cancer Treat Res. 2005;127:1-14.

66.  Terada KY, Shimuzu DM, WongJH.  Outcome for patients with T1 squamous
cell cancer of the vulva undergoing Sentinel Node Biopsy.  Gynecol Oncol 2006;
102:200-203.

67.  Chang SKY, Tominaga, GT, Wong JH, Weldon EJ, Kaan KT.  Risk for factors
for water sports related cervical spine injuries.  J Trauma 2006;60:1041-1046.

68.  Truong C, Wong JH, Lum SS, Morgan JW, Roy-Chowdhury S.  The impact of
hospital volume of number of nodes retrieved and outcome in colorectal cancer. 
Am Surg 2008;74:944-947.

69.  Namm J, Ng M, Lum SS, Roy-Chowdhury S, Morgan JP, Wong JH. 
Quantitating the impact of stage migration on outcome in node negative
colorectal cancer. JACS 2008;207:882-887.

70.  Olaya W, Wong JH, Morgan J, Roy-Chowdhury S, Lum SS.  Disparities in the
surgical management of women with stage I breast cancer.  Am Surg 2009;
198:869-872.

71.  Ng M, Roy-Chowdhury S, Morgan JW, Lum SS, Wong JH.  The impact of the
ratio of positive to total lymph nodes examined and outcome in colorectal
cancer. Am Surg 2009;198:873-876.

72.  Tan J, Bagnell M, Morgan J, Wong JH, Roy-chowdhury S, Lum SS. 
The identification and treatment of isolated tumor cells reflect disparities
in the delivery of breast cancer care.  Am J Surg 2009;198:508-510.

73.  Olaya W, Esquival P, Wong JH, Morgan J, Freeberg A, Roy-Chowdhury S,
Lum SS. Disparities in BRCA testing:  When insurance coverage is not barrier. 
Am J Surg 2009;198:562-565.

Submitted Manuscripts

1.  Roy-Chowdhury,  Truong C, Lum SS, Morgan JW, Wong JH.  Lymph node
counts: An indicator of quality in colorectal cancer?    

2.  Roy-Chowdhury S,  Kempton S, Truong C, Lum SS, Morgan JW, Wong JH,
The impact of young age on prognosis in colon cancer.

Scholarly Book Chapters

1.  Morton DL, Wong JH, Kirkwood J, Parker R:  Malignant Melanoma. in
Cancer Medicine. eds. Hillard JF, Frei E III, Bast RC, Kufe DW, Morton DL,
Weichselbaum RR. Lea & Febiger, Philadelphia, 1993, pp 1793-1824.

2.  Wong JH, Morton DL: Treatment options in the management of primary mucosal
melanoma.  In Malignant melanoma:  Medical and Surgical Managment. 
eds. Lejeune FJ, Chaudhuri PK, Das Gupta TK.  McGraw Hill, New York, 1994
pp 337-342.

3.  Wong JH, Cameron R:  Melanoma. in An Overview of Cancer:  Practical Oncology.
ed Cameron R. Appelton and Lange Publishing Co. Norwalk, 1994, pp 118-132.

4.  Haskell CM, Wong JH:  Carcinoid Tumors. in Cancer Treatment, 4th ed. ed Haskell
CM. W.B. Saunder Co., Philadelphia, 1995, pp766-766.

5.  Haskell CM, Wong JH:  Pheochromocytoma. in Cancer Treatment, 4th ed. ed
Haskell CM. W.B.Saunders Co., Philadelphia, 1995, pp762-766.

6.  Haskell CM, Wong JH:  Adrenal Cortex. in Cancer Treatment, 4th ed. ed Haskell
CM. W.B. Saunders Co., Philadelphia, 1995, pp758-762.

7.  Leong SPL and Wong JH:  Guest Editors Surg Clinics of North America:
Sentinel Lymph Nodes in Human Solid Cancer. 2000:80.

8.  Wong JH:  The Development and Rationale for Sentinel Lymph Node Dissection. 
in Atlas of Selective Sentinel Lymph Node Dissection for Melanoma and Breast Cancer.
ed. Leong SPL.  Kluwer Academic Publishers, Boston, 2002, pp1-7.

9.  Wong JH:  The Development of Intraoperative Lymphatic Mapping and Selective Lymphadenectomy:  A Historical Perspective.  In Selective Sentinel Lymphadenectomy for Human Solid Cancer.  ed. Leong SPL, Kitagawa Y, Kitajima M.  Springer, New York, 2005,
pp1-15.

Published Abstracts               

1.  Wong JH, Cagle LA, Morton DL:  Surgical treatment of metastatic melanoma
(Stage III) from an unknown primary. Proc Am Soc Clin Oncol l987;6:212.

2.  Gupta RK, Wong JH, Morton DL:  Increase in antibody level to a tumor
associated antigen in melanoma patients undergoing immunotherapy with a
tumor cell vaccine. Proc Am Soc Clin Oncol l987;6:249.

3.  Wong JH, Gupta RK, Eilber FR, Morton DL:  Documentation of the presence
of a melanoma tumor associated antigen on the cell surface. Proc Am Soc Clin
Oncol l987; 6:242. 

4.  Wong JH, Gupta RK, Morton DL:  Demonstration of a cell surface fetal antigen
in circulating immune complexes of melanoma patients. Proc Am Assoc Cancer
Res l987; 28:357.

5.  Euhus DM, Gupta RK, Wong JH, Ramming KA, Morton DL:  Effects of melanoma
cell vaccine on levels of antibody to a tumor associated antigen in melanoma
patients. Proc Am Assoc Cancer Res l987;28:349.

6.  Gupta RK, Wong JH, Morton DL:  Clinical relevance of a tumor associated
antigen in malignant melanoma. J Steroid Chem 1987;28:1255.

7.  Wong JH, Cagle LA, Morton DL:  Surgical treatment of melanoma metastatic
to lymph nodes from an unknown primary.  Proc Soc Surg Onc 1987;40:70.

8.  Wong JH, Cagle LA, Storm FK, Morton DL:  The natural history of surgically
treated primary mucosal melanoma.  Proc Pacific Coast Surg Asso 1987;58:23.

9.  Wong JH, Euhus DM, Morton DL:  Surgical resection of melanoma metastatic
to lung. Proc Pacific Coast Surg Assoc 1988;59:21.

10.  Euhus D, Langsford C, Gupta R, Wong JH, Morton DL:  Measurement of a
glycoprotein tumor associated antigen (TAA) using antibodies of different
isotypes from a melanoma patient. Proc FASEB J 1988;2:A1836.

11.  Euhus DM, Gupta RK, Wong JH, Morton DL:  Demonstration and isolation of
a glycoprotein tumor associated antigen from sera of melanoma patients.
Proc Am Soc Clin Oncol 1988;7:44.

12.Euhus DM, Gupta RK, Wong JH, Ramming KP, Morton DL:  Murine monoclonal
antibody to a glycoprotein tumor associated antigen in sera and urine of
melanoma patients. Proc Am Assoc Cancer Res 1988;29:393.

13.  Gupta RK, Wong JH, Euhus DM, Morton DL:  Immunoprognostic significance
of tumor associated antigen specific immune complexes in melanoma patients.
Proc Am Assoc Cancer Res 1988;29:390.

14.  Wong JH, Gupta RK, Huth JH, Euhus DM, Morton DL:  Augmentation of
anti-fetal antigen antibody levels in melanoma patients undergoing active
specific immunotherapy with a tumor cell vaccine.
Proc Am Soc Clin Oncol 1988;7:248.

15.  Wong JH, Gupta RK, Euhus DM, Morton DL:  69.5 Kd glycoprotein fetal
antigen tumor marker in melanoma. Proc Am Soc Clin Oncol 1988;7:252.

16.  Wong JH, Kopald KH, Nizze A, Sterns EE, Morton DL:  The prognostic
significance of pregnancy in stage I melanoma.  Proc Pacific Coast
Surg Assoc 1989;60:43.

17.  Sondak VK, Wong JH, Kern DH, Lazar GS, Storm FK: Isolation limb perfusion
with ARA-C and cisplatin for malignant melanoma: Clinical investigation of
an in vitro observation. Proc Am Soc Clin Oncol 1989;8:282.

18.  Cochran AJ, Farzad Z, Ogbechie H, Economou J, Wong JH,
McBride W, Morton DL: The effect of lymph node culture supernatants
on the growth of cultured human melanoma cells.
Proc Am Assoc Cancer Res 1989;30:85.

19.  Gupta RK, Wong JH, Morton DL:  Correlation of humor immune response
to a melanoma tumor associated antigen with survival of melanoma patients
receiving active specific immunotherapy. Proc Am Assoc Cancer Res 1989;30:344.

20.  Wong JH, Xu SH, Gupta RK, Morton DL:  IgG monoclonal antibody to
detect and isolate antigen specific immune complexes from sera of melanoma
patients. Proc Am Assoc Cancer Res 1989;30:355.

21.  Wong JH, Xu SH, Gupta RK, Morton DL:  Antigen specific immune complexes
as a tumor marker of recurrent melanoma.  Proc Soc Surg Onc 1989;42:166.

22.  Wong JH, Xu SH, Skinner KA, Foshag LJ, Morton DL:  Prospective evaluation
of the utility of antigen specific immune complexes in detecting recurrent melanoma. 
Proc Soc Surg Onc 1990;44:60-61.

23.  Wong JH, Xu SH, Saxton RE, Gupta RK, Morton DL:  Correlation of tumor
associated antigen-specific immune complexes in sera of melanoma patients
with recurrent disease. Proc Am Soc Clin Oncol 1990;9:278.

24.  Bauer R, Kopald K, Lee J, Wong J, Morton D:  Long term results of i
ntralesional BCG for locally advanced recurrent melanoma.
Proc Am Soc Clin Oncol 1990;9:276.

25.  Wong JH, Xu SH, Saxton RE, Morton DL:  Cloning of phage DNA specifying a
melanoma tumor associated antigen. Proc Am Assoc Cancer Res 1990;31:302.

26.  Morton DL, Wong JH: Surgical therapy of metastatic melanoma.
Biologic Agents in the treatment of Cancer 1990.

27.  Foshag LJ, Hoon D, Nizze JA, Wong JH, Morton DL:  Effect of low dose
cyclophosphamide on cellular and humoral immune response in a randomized
trial given in conjunction with active specific immunotherapy.  Proc Soc
of Surg Oncol 1991.

28.  Skinner K, Wong JH, Morton DL:  Operative management of
gastrointestinal metastases from melanoma.  Proc Amer Soc
Clin Oncol 1991;10:295.

29.  Skinner K, Chiu R, Wong JH:  Expression of the retinoblastoma gene in
human melanoma. Proc Am Assoc Cancer Res 1991;32:300.

30.  Skinner KA, Hunt KK, Engle CJ, Raines MA, Wong JH, Eilber FR,
Economou JS, Chiu RH:  Identification and cloning of a novel gene highly
amplified in a human soft tissue sarcoma. Proc Soc of Surg Oncol 1992;45:164.

31.  Skinner KA, Wong JH, Morton DL, Eilber FR:  Adult spermatic cord sarcomas.
Proc Am Soc Clin Oncol 1992;11:418.

32.  Skinner KA, Wong JH, Chiu RH:  Dexamethasone down-regulates c-jun
expression and inhibits c-jun induction by phorbal esters in human
osteosarcoma cell lines. Proc Am Assoc Cancer Res 1992;33:362.

33.  Law MM, Williams SB, Wong JH:  The role of surgery in the management
of primary lymphoma of the gastrointestinal tract.  Proc Pacific Coast Surg Assoc
1993;64:51.

34.  KM Truelove, JL Jackson, Wong JH:  The prognostic significance of ethnic
origin in Japanese Americans diagnosed with melanoma.  Proc Am Soc
Clin Oncol 1996;15:438.

35.  Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes
examined and staging accuracy in colorectal carcinoma.  Proc Pacific Coast
Surg Assoc 1998;69:13.

36.  Steinemann S, Wong JH. Sentinel node biopsy:  multidisciplinary approach
to ultrastaging malignancy. Proc Int College Surg 1998;60.

37.  Steinemann S, Sumida K, Fukuda R, Wong JH.  Prognostic utility of clinical
exam and primary tumor characteristics in determining extent of axillary node
invovlment in breast cancer.  Proc Pacific Coast Surg Assoc 1999;70:9.

38.  Terada KY, Shimizu DM, Wong JH. Micrometastases and sentinel node
dissection in squamous cell cancer of the vulva. Proc West
Assoc Gyn Oncol 1999;28.

39.  Wong JH, Tauchi P, Namiki T.  Cost effective ultrastaging of carcinoma of
the colon and rectum.  Proc Soc Surg Oncol 2000;53:60.

40.  Sera M, Steinemann S, Belcher T, Cole M, Wong JH.  The impact of time
on the number of sentinel nodes imaged by cutaneous lymphoscintigraphy
in patients with melanoma. Proc Am Soc Clin Oncol 2000:19:565a.

41.  Leong SPL, Balkisson J, Chang A, Wong JH et al.  Correlation of primary
T4 melanoma and incidence of sentinel lymph node micrometastasis from a
multi-center database.  Proc WHO Melanoma Conference, 2000.

42.  Steinemann S, Tom P, Wong JH.  The volume of lymphatic metastases
does not independently influence prognosis in colorectal cancer patients. 
Proc Soc Surg Oncol 2001;54:59.

43.  Wong JH, Johnson DS, Tauchi-Nishi P, Yonehara C, Namiki T. 
Histopathologic validation of ex viov sentinel node staging in carcinoma of
the colon and rectum. Proc 3rd International Sentinel Node
Congress 2002;3:140.

44. Johnson DS, Namiki T, Tauchi-Nishi P, Wong JH.  Ex vivo sentinel node
mapping for carcinoma of the colon and rectum:  Validation of the hypothesis. 
Proc Pacific Coast Surg Assoc 2003;74:69.

45.  Morita S, Tauchi-Nishi P, Yonehara C, Wong JH.  Prognostic characteristics
of gastrointestinal stromal tumors.  Proc Pacific Coast Surg Assoc 2003;74:23.

46.  Tominaga GT, Dzierba AR, Galanis DJ, Wong JH. Are expensive modes of
EMS transport justified?  Quantifying the benefit of rapid transport of trauma
patients. Proc Am Assoc Surg Trauma 2003:62:228

47.  Tominaga GT, Dzierba AR, Galanis DJ, Wong JH.  Early transport to
referral trauma center decreases length of stay in patients with closed head
injuries. Proc Am Assoc Surg Trauma 2003;62:241.

48.  Tominaga GT, Garcia G, Dzierba A, Wong JH.  Amphetamines-Its toll
on the trauma system.  Proc Pacific Coast Surg Assoc 2004;75:75.

49.  Hemmings DE, Johnson DS, Tominaga, GT, Wong JH.  Cutaneous
melanoma in a multi-ethnic population:  Is this a different disease?  Proc
Pacific Coast
Surg Assoc 2004;75:111.

50.  Hsu A, Johson DS, Hemmings D, Imai T, Tominaga GT, Wong JH.  Quality
contolling colorectal cancer staging:  The importance of documenting the
process in improving staging of node-negative colorectal cancer patients. 
Proc Pacific Coast Surgic Assoc 2005;76:121.

51.  Tominaga GT, Halford P, Dzierba A, Wong JH.  Improved outcome in
blunt thoracic aortic injuries following American College of Surgeons trauma
center verification. Proc Pacific Coast Surg Assoc 2005;76:79.

52.  Tominaga GT, Wong JH.  Factores related to outcome in blunt thoracic
aortic injuries: A clinical and autopsy review.  Proc Am Associ Surg Trauma
2005;64:250. 53. 

53. Hemmings DH, Wong JH.  The prognostic significance of ethnicity in
colorectal cancer. Proc Pacific Coast Surg Assoc 2006;77:98.

54.  Wong JH, Hemmings DH.  The prognostic significance of node ratios in
node positive colorectal cancer.  Proc Pacific Coast Surg Assoc 2007;78:34.

55.  Truong C, Wong JH, Lum SS, Morgan JW, Roy-Chowdhury S.  The impact of
hospital volume on number of nodes retrieved and outcome in colorectal cancer. 
Proc S Calif Chap ACS 2008;19:41.

56.  Namm J, Roy-Chowdhury S, Lum SS, Wong JH.  Better surgery or bettery
staging?  Quantitating the impact of stage migration on outcome in node
negative colorectal cancer.  Proc Pacific Coast Surg Assoc 2008;79:32.

57.  Ng M, Brown S, Esquival P, Roy-Chowdhury S, Wong JH, Lum SS.  Patient
distress at initial breast health center consultation is associated with factors
other than diagnosis.  Proc Am Soc Breast Surg 2008;9:69.

58.  Depew, A., Kuhn, M., Wong, JH., Lum, S.  Successful Treatment of Chronic
Post-Mastectomy Seroma with Sodium Morrhuate Sclerosis:  A Case Report  
Proc AmSoc Breast Dis; 2008;32.

59.  Ng M, Roy-Chowdhury S, Lum SS, Morgan JW, Wong JH.  The prognostic
significance of the ratio of positive to total nodes in colorectal cancer.
Proc Am Soc Clin Oncol 2008;44:189s.

60.  Valenzuela W, Wong JH, Morgan J, Roy-Chowdhury S, Lum SS. 
Disparities in the surgical management of women with stage I breast cancer. 
Proc S Calif Chap ACS 2009;20:11.

61.  Truong C, Lum SS, Morgan JW, Wong JH, Roy-chowdhury S. 
The impact of young age on outcome in colon cancer. 
Proc S Calif Chap ACS 2009;20:16.

62.  Ng M, Roy-Chowdhury S, Morgan JW, Lum SS, Wong JH.  The
number of nodes examined and outcome in node positive colorectal cancer. 
Proc S Calif Chap ACS
2009;20:41.

63.  Truong C, Roy-Chowdhury S. Lum SS, Morgan JW, Wong JH.  Lymph
node counts: An indicator of quality in colorectal cancer?  Proc Pacific Coast
Surg Assoc 2009;80:105.

64.  Tan J, Bagnell M, Morgan J, Wong JH, Roy-chowdhury S, Lum SS.  The
identification and treatment of isolated tumor cells reflect disparities in the
delivery of breast cancer care.  Proc Am Soc Breast Surg 2009;10:

65.  Valenzuela W, Esquival P, Wong JH, Morgan J, Freeberg A,
Roy-Chowdhury S,  Lum SS. Disparities in BRCA testing:  When insurance
coverage is not barrier. Proc Am Soc Breast Surg 2009;10:.

66.  Truong C, Kempton S, Lum S, Morgan JW, Wong JH, Roy-Chowdhury S.
The impact of young age on prognosis in colon cancer.  Proc Am S Clin Oncol
2009;27:186S.